Alchemee, LLC Initiates Class II Recall for Benzene-Contaminated Proactiv Skin Smoothing Exfoliator
Alchemee, LLC has initiated a Class II recall for 3,500 bottles of Proactiv Skin Smoothing Exfoliator (Benzoyl Peroxide 2.5%) due to benzene contamination. This voluntary, nationwide recall highlights critical quality control gaps in topical drug manufacturing, demanding immediate action from procurement and regulatory teams to mitigate supply chain risks and protect brand integrity.
FDA Class II Recall: Benzene Contamination in Alchemee's Proactiv Exfoliator
Alchemee, LLC has initiated a Class II voluntary recall for 3,500 bottles of its Proactiv Skin Smoothing Exfoliator, a product containing Benzoyl Peroxide 2.5%. This critical action, designated recall number D-0360-2025, was prompted by the confirmed presence of benzene, a known human carcinogen, within the product. The recall was initiated by Alchemee, LLC on March 12, 2025, with the FDA classifying it as Class II on April 9, 2025. The affected product, distributed nationwide across the USA, includes specific packaging configurations: a 6 fl. oz. (177.4 mL) bottle with UPC 7 35786 01528 2, and a 0.33 OZ (9.45g) size with UPC 8 42944 10223 1. The specific lot identified is V4204A, with an expiration date of July 31, 2025. The recalling firm's address is 3 Skyline Dr, Hawthorne, NY 10532-2174, while the product is distributed by Alchemee, LLC from Santa Monica, CA 90401. For procurement directors, this necessitates immediate verification of existing inventory against the specified lot numbers and UPCs to prevent distribution of contaminated product. Regulatory affairs heads must ensure all reporting obligations to the FDA are met promptly, given the Class II classification indicates potential for temporary or medically reversible adverse health consequences. Supply chain VPs need to implement robust quarantine and return procedures for the 3,500 affected bottles, minimizing further exposure and ensuring compliance with regulatory mandates.
Critical Quality Control Failures: Implications for Benzoyl Peroxide Sourcing
The detection of benzene in Proactiv Skin Smoothing Exfoliator underscores a significant failure in quality control processes, particularly concerning raw material sourcing and manufacturing hygiene. Benzoyl Peroxide, the active ingredient, is a widely used topical agent, and its contamination with benzene presents a serious challenge for formulators across the dermatology and consumer health sectors. For procurement teams, this event demands an immediate and thorough re-evaluation of all suppliers providing Benzoyl Peroxide and related excipients. It is imperative to scrutinize Certificates of Analysis (CoAs) for comprehensive impurity profiles, specifically testing for benzene and other volatile organic compounds (VOCs), rather than relying solely on standard specifications. Supply chain VPs must revisit and strengthen quality agreements with contract manufacturing organizations (CMOs) and raw material vendors, ensuring that robust analytical testing methods are in place and routinely performed to detect unexpected contaminants. This incident highlights that even well-established active pharmaceutical ingredients (APIs) can carry inherent risks if supplier qualification and ongoing monitoring are not rigorously maintained. Business development executives should recognize the heightened scrutiny this event places on product safety and quality, potentially influencing consumer purchasing decisions and market share in the competitive topical drug market.
Navigating Regulatory Scrutiny and Market Repercussions for Topical Drug Products
The Class II classification of this recall by the FDA signals a serious health risk, prompting a heightened level of regulatory oversight. While Alchemee, LLC initiated this recall voluntarily, the FDA's involvement ensures that all necessary corrective actions are taken. For regulatory affairs heads, this means preparing for potential inquiries from the FDA regarding the root cause analysis, corrective and preventive actions (CAPAs), and the effectiveness of the recall. The voluntary nature of the recall, initiated via e-mail, indicates the firm's awareness and response, but the underlying issue of chemical contamination will likely lead to increased scrutiny of their manufacturing practices and quality management systems. Supply chain VPs must ensure that recall logistics are executed flawlessly to minimize further regulatory exposure and potential penalties. Beyond immediate compliance, the presence of benzene in a widely recognized consumer product like Proactiv carries significant reputational risks. Business development executives must anticipate potential erosion of consumer trust and brand loyalty, which can impact future sales and market positioning. This incident serves as a stark reminder for all industry players that robust quality assurance throughout the product lifecycle, from raw material to finished good, is paramount not only for regulatory compliance but also for sustaining market credibility and consumer confidence in topical drug products.